Skip to main content
. Author manuscript; available in PMC: 2020 Jan 12.
Published in final edited form as: J Perinatol. 2016 Sep 29;37(1):61–66. doi: 10.1038/jp.2016.159

Table 3.

Calculation of point estimate of incremental cost-effectiveness ratio (iCER)

Parameter Cost ($) Incremental cost (Δ cost) Effectiveness (%) Incremental effectiveness (Δ effectiveness) iCER (Δcost/Δeffectiveness)
nCPAP 140 404 0.633
NIPPV 143 745 3341 0.616 − 0.017 Dominateda

Abbreviations: nCPAP, nasal continuous positive pressure; NIPPV, nasal intermittent positive pressure ventilation.

a

iCER: −197,020.